Co-authors of the Ebola Therapy Test in Democratic Republic of Congo (DRC) announced significant progress in the response to the epidemic. Two of the four drugs tested are more effective in treating Ebola. This will improve the chances of survival of patients, the WHO notes.

"In the future, these are the only drugs with which future patients will be treated. "This organization reveals. This WHO initiative is the first ever multi-drug randomized controlled test to evaluate the safety and efficacy of four drugs used to treat Ebola patients.

Originally developed as a Multi-Epidemic and Multi-Country Study (PALM), ("Together, Save Lives") was launched in November 2018. It is part of the emergency response in the DRC, collaboration with a broad alliance of partners, including DRC national authorities.

These partners include the Institute for Biomedical Research (INRB), the Ministry of Health, the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the US National Institutes of Health, the Alliance for International Medical Action (ALIMA), Doctors Without Borders (MSF), International Medical Corps (IMC) and other organizations.

Meanwhile, on the ground, measures are still being taken to prevent the spread of the epidemic. Thermometers are installed in borders to prevent the spread of this deadly virus through other territories of the country or abroad. "There is remote temperature sensing.

There are devices that can detect people who have fever, avoiding panic, "warned to Radio Okapi, Jean-Marie Kayembe, a member of the Ebola response team. "In our country, there is the fever attributable to malaria, for example. That's why this remote detection should not be entrusted to the sorcerer's apprentices, but to the trained people who can really decipher the [suspicious] cases in order to prevent an uncontrollable spread of the infection", he added. Handwashing devices are also installed at airports, including the N'djili International Airport to stop this epidemic.